New Evidence Available
Updated Recommendation
A new evidence synthesis was published:2025, Medical eligibility criteria for contraceptive use, 6th ed.
View latest version (2025)Bibliographic information
GuidelineMedical eligibility criteria for contraceptive use
Year of Publication2015
Issuing InstitutionWorld Health Organization
Recommendation
Retired
Women living with severe or advanced HIV clinical disease (WHO stage 3 or 4) and taking any Non-nucleoside/ nucleotide reverse transcriptase inhibitor (NNRTI) generally should not initiate use of the levonorgestrel-releasing intrauterine device(LNG-IUD) until their illness has improved to asymptomatic or mild HIV clinical disease.
Certainty of evidence
Low